Aspiriant LLC’s U.S. Core Equity 2 Portfolio ETF Class Shares DFAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-320,192
Closed -$14.2M – 432
2026
Q2
$14.2M Buy
320,192
+8
+0% +$342 0.35% 42
2026
Q1
$12.4M Buy
320,184
+9
+0% +$363 0.35% 40
2025
Q4
$12.7M Buy
320,175
+8
+0% +$312 0.36% 40
2025
Q3
$12.3M Sell
320,167
-4,276
-1% -$160K 0.38% 37
2025
Q2
$11.6M Buy
324,443
+10,333
+3% +$345K 0.37% 37
2025
Q1
$10.4M Buy
314,110
+32,074
+11% +$1.11M 0.36% 35
2024
Q4
$9.8M Buy
282,036
+10
+0% +$352 0.35% 36
2024
Q3
$9.7M Sell
282,026
-468
-0.2% -$15.5K 0.37% 37
2024
Q2
$9.11M Buy
282,494
+488
+0.2% +$15.4K 0.37% 37
2024
Q1
$9.01M Buy
282,006
+7
+0% +$211 0.37% 38
2023
Q4
$8.24M Buy
281,999
+13
+0% +$352 0.37% 39
2023
Q3
$7.39M Buy
281,986
+12
+0% +$328 0.38% 38
2023
Q2
$7.66M Buy
281,974
+11
+0% +$284 0.39% 38
2023
Q1
$7.18M Buy
281,963
+8
+0% +$203 0.38% 39
2022
Q4
$6.85M Buy
281,955
+18
+0% +$438 0.35% 41
2022
Q3
$6.27M Buy
281,937
+13
+0% +$319 0.31% 43
2022
Q2
$6.57M Sell
281,924
-4,580
-2% -$116K 0.32% 42
2022
Q1
$7.9M Sell
286,504
-409
-0.1% -$11.2K 0.43% 35
2021
Q4
$8.31M Buy
286,913
+14
+0% +$395 0.44% 29
2021
Q3
$7.62M Buy
286,899
+9
+0% +$245 0.45% 30
2021
Q2
$7.74M Buy
+286,890
New +$7.62M 0.44% 29

Other funds holding DFAC

Aspiriant LLC's DFAC Position: Q3 2026 in Review

Aspiriant LLC sold out of U.S. Core Equity 2 Portfolio ETF Class Shares (DFAC) in Q3 2026, closing a stake of 320,192 shares — an estimated $14.2M sold.

Aspiriant LLC first reported a position in DFAC in Q2 2021 and held it in 21 quarters. The position peaked at $14.2M in Q2 2026. 226 funds tracked by Wall St. Rank hold DFAC as of Q3 2026.

  • Aspiriant LLC reported no remaining U.S. Core Equity 2 Portfolio ETF Class Shares position as of Q3 2026 after selling out during the quarter.
  • Aspiriant LLC sold 320,192 U.S. Core Equity 2 Portfolio ETF Class Shares shares in Q3 2026, an estimated $14.2M.
  • Aspiriant LLC first reported a position in U.S. Core Equity 2 Portfolio ETF Class Shares in Q2 2021 and held it in 21 quarters.
  • Aspiriant LLC's U.S. Core Equity 2 Portfolio ETF Class Shares position peaked at $14.2M in Q2 2026.
  • 226 funds tracked by Wall St. Rank held U.S. Core Equity 2 Portfolio ETF Class Shares as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.